Mirari Biosciences Inc is categorized under Diagnostic Substances in Rockville, MD and active since 2000.
Mirari Biosciences Inc was established in 2000, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Diagnostic Substances business, which does work in the B2B market, and is classified as a Diagnostic Substances, under code number 325412 by the NAICS.
If you are seeking more information, feel free to contact Mark Martin at the company’s single location by writing to 6516 Old Farm Court, Rockville, Maryland MD 20852 or by phoning (240) 447-6456. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Mirari Biosciences Inc |
| Contact Person: | Mark Martin |
| Address: | 6516 Old Farm Court, Rockville, Maryland 20852 |
| Phone Number: | (240) 447-6456 |
| Website Address: | miraribiosciences.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Diagnostic Substances |
| SIC Code: | 2835 |
| NAICS Code: | 325412 |
| Share This Business: |
Mirari Biosciences Inc was started in 2000 to provide professional Diagnostic Substances under the SIC code 2835 and NAICS code 325412. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Mark Martin for inquiries that concern Mirari Biosciences Inc by calling the company number (240) 447-6456, as your correspondence is most welcome. Additionally, the physical location of the single location of Mirari Biosciences Inc can be found at the coordinates 39.046325,-77.134435 as well as the street address 6516 Old Farm Court in Rockville, Maryland 20852.
For its online presence, you may visit Mirari Biosciences Inc’s website at miraribiosciences.com and engage with its social media outlets through on Twitter and on Facebook.